Summary of product characteristics

    • [PDF File]SUMMARY OF PRODUCT CHARACTERISTICS

      https://info.5y1.org/summary-of-product-characteristics_1_d24ef7.html

      SUMMARY OF PRODUCT CHARACTERISTICS ... As for every active product, this medicine can provoke more or less some side effects in certain patients: - Slight somnolence, appearing at the beginning of the treatment and disappearing spontaneously during the rest of the treatment.

      summary of product characteristics uk


    • [PDF File]SUMMARY OF PRODUCT CHARACTERISTICS

      https://info.5y1.org/summary-of-product-characteristics_1_932a49.html

      SUMMARY OF PRODUCT CHARACTERISTICS . page 1 of 12 . Artesunate 60 mg for injection WHOPAR part 4 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 . 1. NAME OF THE MEDICINAL PRODUCT . …

      key product characteristics guideline


    • [PDF File]SmPC : summary of product characteristics

      https://info.5y1.org/summary-of-product-characteristics_1_2cf5e1.html

      Summary of product characteristics. Genomic factors (5/8) • Pharmacogenomics (PGx) is defined as the study of variations of DNA and RNA characteristics as related to drug response. The knowledge in this field is ever increasing with the potential to improve the discovery, development and use of medicines.

      electronic medical compendium


    • [PDF File]SUMMARY OF PRODUCT CHARACTERISTICS

      https://info.5y1.org/summary-of-product-characteristics_1_1a8dc5.html

      This product is intended for use in children. Nonetheless, safety information is provided for adult health issues such as pregnancy and lactation, to allow full access to all relevant information. 4.2 Posology and method of administration For acute and persistent diarrhoea Children aged less than 6 months: ½ tablet once daily for 10–14 days.

      smpc


    • [PDF File]SUMMARY OF PRODUCT CHARACTERISTICS

      https://info.5y1.org/summary-of-product-characteristics_1_f1f114.html

      SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Priadel 200mg prolonged release tablets. Priadel 400mg prolonged release tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Priadel 200 tablets contain 200mg lithium carbonate. Priadel 400 tablets contain 400mg lithium carbonate.

      summary of product characteristics eu


    • [PDF File]Summary of Product Characteristics

      https://info.5y1.org/summary-of-product-characteristics_1_1701de.html

      Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Trasylol 10,000 KIU/ml solution for injection or infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Aprotinin 10,000 KIU (Kallikrein Inhibitor Units) For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection/infusion

      ema summary of product characteristics


    • [PDF File]SUMMARY OF PRODUCT CHARACTERISTICS - Spiriva Global

      https://info.5y1.org/summary-of-product-characteristics_1_5ac6ce.html

      SUMMARY OF PRODUCT CHARACTERISTICS. Version: 13 January 2017 . 2 . 1. NAME OF THE MEDICINAL PRODUCT. Spiriva Respimat 2.5 microgram, inhalation solution . 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. The delivered dose is 2.5 microgram tiotropium per puff (2 puffs comprise one medicinal dose) and is

      humira summary of product characteristics


    • [PDF File]SUMMARY OF PRODUCT CHARACTERISTICS

      https://info.5y1.org/summary-of-product-characteristics_1_e33466.html

      Summary of Product Characteristics Emergent BioSolutions, Inc. Confidential and Proprietary Page 8 of 13 Surveillance data collected by the U.S Centers for Disease Control and Prevention (CDC) between 1962 and 1974 identified 27 cases of anthrax disease, 24 in unvaccinated individuals and 3 where vaccine schedule was incomplete.

      summary of product characteristics guideline


    • [PDF File]ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

      https://info.5y1.org/summary-of-product-characteristics_1_06860b.html

      SUMMARY OF PRODUCT CHARACTERISTICS. 2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

      summary of product characteristics uk


    • [PDF File]SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING …

      https://info.5y1.org/summary-of-product-characteristics_1_2ecdca.html

      The medicinal product is intended for inhalation use only. The cartridge can only be inserted and used in the Respimat inhaler (see 4.2). Two puffs from the Respimat inhaler comprise one medicinal dose. The recommended dose for adults is 5 microgram tiotropium given as two puffs from the Respimat inhaler once daily, at the same time of the day.

      key product characteristics guideline


Nearby & related entries: